Page last updated: 2024-08-23

raloxifene hydrochloride and leuprolide

raloxifene hydrochloride has been researched along with leuprolide in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (66.67)	29.6817
2010's	3 (25.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Colao, A; Lombardi, G; Mastrantonio, P; Morelli, M; Nappi, C; Orio, F; Palomba, S; Pellicano, M; Russo, T; Zullo, F	1
Colao, A; Lombardi, G; Nappi, C; Orio, F; Palomba, S; Panici, PL; Russo, T; Tauchmanovà, L; Zullo, F; Zupi, E	1
Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F	1
Cascella, T; Doldo, P; Falbo, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Zullo, F	1
Izutsu, T; Sugiyama, T	1
Brown, PH; Uray, IP	1
Lingxia, X; Taixiang, W; Xiaoyan, C	1
Chen, X; Wu, T; Xie, L	1
Amorosi, A; Annunziata, G; Oppedisano, R; Palomba, S; Zullo, F	1
Chen, XY; Deng, L; Wu, T; Xie, L; Yang, J	1
Campbell, H; Cui, J; Deane, KD; Ercan, A; Finkelstein, JS; Hausmann, JS; Kaiser, UB; Kohrt, WM; Lauc, G; Nigrovic, PA; Pezer, M; Rudd, PM; Wilson, JF; Yu, EW	1
Dhande, R; Patel, A; Thakkar, H	1

Reviews

5 review(s) available for raloxifene hydrochloride and leuprolide

Article	Year
[Hormone therapy for uterine corpus cancer--introduction]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10 Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome	2004
Prevention of breast cancer: current state of the science and future opportunities. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Female; Forecasting; Humans; Leuprolide; Mammary Neoplasms, Experimental; Mice; Middle Aged; Ovariectomy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Rats; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen	2006
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2 Topics: Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms	2007
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4 Topics: Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms	2007
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10 Topics: Adult; Female; Humans; Leiomyoma; Leuprolide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Neoplasms; Young Adult	2012

Trials

4 trial(s) available for raloxifene hydrochloride and leuprolide

Article	Year
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10 Topics: Adult; Body Mass Index; Bone and Bones; Bone Density; Calcium; Delayed-Action Preparations; Female; Femur; Humans; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Osteoporosis; Phosphorus; Placebos; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uterine Neoplasms	2002
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:12 Topics: Delayed-Action Preparations; Female; Hot Flashes; Humans; Leiomyoma; Leuprolide; Menorrhagia; Pain; Patient Dropouts; Placebos; Premenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Neoplasms	2002
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene. Human reproduction (Oxford, England), 2004, Volume: 19, Issue:2 Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12	2004
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Human reproduction (Oxford, England), 2004, Volume: 19, Issue:6 Topics: Antineoplastic Agents, Hormonal; Blood Glucose; Bone Density; Bone Remodeling; Delayed-Action Preparations; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Lipids; Longitudinal Studies; Middle Aged; Patient Dropouts; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Severity of Illness Index; Treatment Outcome; Uterine Neoplasms; Vasomotor System	2004

Other Studies

3 other study(ies) available for raloxifene hydrochloride and leuprolide

Article	Year
Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: a case report. Gynecologic oncology, 2011, Volume: 123, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Leuprolide; Myxoma; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Raloxifene Hydrochloride; Vaginal Neoplasms	2011
Estrogens regulate glycosylation of IgG in women and men. JCI insight, 2017, 02-23, Volume: 2, Issue:4 Topics: Adult; Anastrozole; Androgens; Aromatase Inhibitors; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Fertility Agents, Female; Galactose; Glycosylation; Gonadotropin-Releasing Hormone; Goserelin; Healthy Volunteers; Humans; Immunoglobulin G; Leuprolide; Male; Middle Aged; Polysaccharides; Postmenopause; Premenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Factors; Testosterone	2017
Development of intravaginal rod insert bearing liposomal raloxifene hydrochloride and Leuprolide acetate as a potential carrier for uterine targeting. The Journal of pharmacy and pharmacology, 2021, Mar-27, Volume: 73, Issue:5 Topics: Administration, Intravaginal; Animals; Apoptosis; Cholesterol; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Goats; Humans; Leuprolide; Liposomes; MCF-7 Cells; Particle Size; Phosphatidylcholines; Rabbits; Raloxifene Hydrochloride; Uterus; Vagina	2021